110 related articles for article (PubMed ID: 228834)
1. The relation between Epstein-Barr virus antibodies and clinical symptomatology and immunodeficiency in patients with Hodgkin's disease.
Mochanko K; Fejes M; Breazavscek DM; Suarez A; Bachmann AE
Cancer; 1979 Dec; 44(6):2065-70. PubMed ID: 228834
[TBL] [Abstract][Full Text] [Related]
2. [Elevated Epstein-Barr virus antibodies in patients with Hodgkin's disease].
Kuljić-Kapulica N
Srp Arh Celok Lek; 1998; 126(3-4):97-100. PubMed ID: 9863363
[TBL] [Abstract][Full Text] [Related]
3. Correlation between mixed lymphocyte cultures and anti-Epstein Barr virus (EBV) antibodies in Hodgkin's disease and non Hodgkin lymphoma patients.
Sasiain MC; Fejes M; Ares BR; Brezavscek D; Bachmann AE
Biomedicine; 1981 Oct; 35(5):153-6. PubMed ID: 6274439
[TBL] [Abstract][Full Text] [Related]
4. Immunological characterization of Hodgkin's and non-Hodgkin's lymphoma patients with high antibody titers against Epstein-Barr virus-associated antigens.
Masucci G; Mellstedt H; Masucci MG; Szigeti R; Ernberg I; Björkholm M; Tsukuda K; Henle G; Henle W; Pearson G
Cancer Res; 1984 Mar; 44(3):1288-300. PubMed ID: 6318984
[TBL] [Abstract][Full Text] [Related]
5. Antibodies to Epstein-Barr virus-associated nuclear antigen and to other viral and non-viral antigens in Hodgkin's disease.
Rocchi G; Tosato G; Papa G; Ragona G
Int J Cancer; 1975 Aug; 16(2):323-8. PubMed ID: 168161
[TBL] [Abstract][Full Text] [Related]
6. Relationship between clinical stage, histopathology and antibody titers against the second Epstein-Barr virus nuclear antigen (EBNA-2) in non-Hodgkin's lymphoma patients.
Masucci G; Mellstedt H; Henle G; Henle W; Rymo L; Masucci MG; Ernberg I; Klein G
Int J Cancer; 1989 Jun; 43(6):1017-21. PubMed ID: 2543639
[TBL] [Abstract][Full Text] [Related]
7. Humoral antibodies to the capsid antigen of Epstein-Barr virus in Hodgkin's disease.
Stepina VN; Gourtsevicz VE; Mazurenko NP; Yarymova NM; Kaverznyeva MM; Lorye YI
Neoplasma; 1976; 23(5):523-32. PubMed ID: 185535
[TBL] [Abstract][Full Text] [Related]
8. Immune response to Epstein-Barr virus (EBV) in ataxia-telangiectasia: EBV-specific antibody patterns and their relation to cell-mediated immunity.
Berkel AI; Henle W; Henle G; Ersoy F; Sanal O; Klein G; Yeğin O
Kroc Found Ser; 1985; 19():287-300. PubMed ID: 2999343
[TBL] [Abstract][Full Text] [Related]
9. Longitudinal study of Epstein-Barr virus antibody titers and excretion in pediatric patients with Hodgkin's disease.
Lange B; Arbeter A; Hewetson J; Henle W
Int J Cancer; 1978 Nov; 22(5):521-7. PubMed ID: 82539
[TBL] [Abstract][Full Text] [Related]
10. Epstein-Barr virus infections in Brazil. II. Hodgkin's disease.
Evans AS; Carvalho RP; Frost P; Jamra M; Pozzi DH
J Natl Cancer Inst; 1978 Jul; 61(1):19-26. PubMed ID: 209202
[TBL] [Abstract][Full Text] [Related]
11. Epstein-Barr virus antibody in childhood Hodgkin's disease.
Shope TC; Khalifa AS; Smith ST; Cushing B
Am J Dis Child; 1982 Aug; 136(8):701-3. PubMed ID: 6285693
[TBL] [Abstract][Full Text] [Related]
12. Epstein Barr virus (EBV) carrying cells in blood of Hodgkin's disease (HD) and non-Hodgkin lymphoma (NHL) patients with high antibody titers against EBV capsid antigens (VCA).
Lewin N; Aman P; Mellstedt H; Carenfelt C; Klein G; Klein E
Anticancer Res; 1990; 10(5A):1213-6. PubMed ID: 2173472
[TBL] [Abstract][Full Text] [Related]
13. Epstein-Barr virus (EBV)-associated antibody patterns in relation to the deficiency of cell-mediated immunity in patients with Hodgkin's disease.
Johansson B; Killander D; Holm G; Mellstedt H; Henle G; Henle W; Klein G; Söderberg G
IARC Sci Publ (1971); 1975; (11 Pt 2):237-47. PubMed ID: 191367
[TBL] [Abstract][Full Text] [Related]
14. Discordant Epstein-Barr virus nuclear antigen (EBNA) antibody patterns in nasopharyngeal carcinoma.
Hewetson JF; Levine PH; Neubauer RH; Rabin H
Int J Cancer; 1982 Nov; 30(5):581-5. PubMed ID: 6295966
[TBL] [Abstract][Full Text] [Related]
15. Cell-mediated immune reactions in three patients with malignant lymphoproliferative diseases in remission and abnormally high Epstein-Barr virus antibody titers.
Masucci MG; Szigeti R; Ernberg I; Björkholm M; Mellstedt H; Henle G; Henle W; Pearson G; Masucci G; Svedmyr E; Johansson B; Klein G
Cancer Res; 1981 Nov; 41(11 Pt 1):4292-301. PubMed ID: 6272973
[TBL] [Abstract][Full Text] [Related]
16. Burkitt's lymphoma: its clinical course in relation to immunologic reactivities to Epstein-Barr virus and tumor-related antigens.
Nkrumah F; Henle W; Henle G; Herberman R; Perkins V; Depue R
J Natl Cancer Inst; 1976 Nov; 57(5):1051-6. PubMed ID: 187787
[TBL] [Abstract][Full Text] [Related]
17. Herpesvirus group antibodies in children with Hodgkin's disease.
Holy J; Hrodek O; Srajer J
Arch Virol; 1977; 53(3):221-33. PubMed ID: 193463
[TBL] [Abstract][Full Text] [Related]
18. Hodgkin's disease and Epstein-Barr virus. Altered antibody pattern before diagnosis.
Mueller N; Evans A; Harris NL; Comstock GW; Jellum E; Magnus K; Orentreich N; Polk BF; Vogelman J
N Engl J Med; 1989 Mar; 320(11):689-95. PubMed ID: 2537928
[TBL] [Abstract][Full Text] [Related]
19. Positive correlation between Epstein-Barr virus viral load and anti-viral capsid immunoglobulin G titers determined for Hodgkin's lymphoma patients and their relatives.
Besson C; Amiel C; Le-Pendeven C; Brice P; Fermé C; Carde P; Hermine O; Raphael M; Abel L; Nicolas JC
J Clin Microbiol; 2006 Jan; 44(1):47-50. PubMed ID: 16390946
[TBL] [Abstract][Full Text] [Related]
20. Seroepidemiological study of relationships between Epstein-Barr virus and rheumatoid arthritis.
Ferrell PB; Aitcheson CT; Pearson GR; Tan EM
J Clin Invest; 1981 Mar; 67(3):681-7. PubMed ID: 6259207
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
